Event
OSCO Presents “Best of” San Antonio Breast Cancer Symposium® Virtual Symposium
The Oklahoma Society of Clinical Oncology, Inc. would like to invite you to attend our 2022 Spring meeting,
Join your colleagues to hear highlights from this state-of-the art symposium on the experimental biology, etiology, prevention, diagnosis and therapy of breast cancer and premalignant breast disease. The “Best of” SABCS is an officially licensed program of the San Antonio Breast Cancer Symposium. This virtual symposium is directed towards Hematologists and Oncologists, Nurses, Pharmacists, Physician Assistants and other health care professionals specializing in Oncology. This meeting will break down the most clinically relevant abstracts from the SABCS annual symposium, providing attendees to hear the latest strategies in oncology education. Note: There is no fee for physicians and allied health personnel to attend, but meeting registration is required.
- “Best of” SABCS®” is an officially licensed program provided through Encore Medical Education.
- This conference is jointly provided by Postgraduate Institute for Medicine and Oklahoma Society of Clinical Oncology, Inc.
- This activity has been approved for a maximum of 3.5 AMA PRA Category 1 Credit(s)™and 3.5 contact hours for Continuing Nursing Education.
Pharmaceutical Companies interested in Corporate Membership? Join here →
Companies interested in a virtual exhibit for Spring and/or Fall Conference? Purchase here →
Show Agenda-
7:30 AM (CDT)Virtual Exhibitor Booths Open
-
7:50 AM - 8:00 AM (CDT)Welcome Remarks & Annual Member Meeting
Jose Eugenio Najera, MD
OSCO President
-
William Dooley, MD
OSCO Treasurer
-
8:00 AM - 8:15 AM (CDT)Break with Virtual Exhibitors
-
8:15 AM - 8:35 AM (CDT)One Week of Whole Breast Radiotherapy As the New Standard of Care - Speaker 1
Professor Charlotte Coles, MBChB, MRCP, FRCR, PhD
Breast Cancer Clinical Oncology and Deputy Health of Department of Oncology
University of Cambridge, United Kingdom
-
8:35 - 8:55One Week of Whole Breast Radiotherapy As the New Standard of Care - Speaker 2
Christina E. Henson, MD
Assistant Professor, Department of Radiation Oncology
Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma
-
8:55 AM - 9:10 AM (CDT)Q&A with Professor Coles
-
9:10 AM - 9:25 AM (CDT)Break with Virtual Exhibitors
-
9:25 AM - 10:20 AM (CDT)Genomic Profiling in Early-Stage ER Positive Breast Cancers
Professor Mitch Dowsett, PhD, FMedSci
Honorary Consultant Clinical Scientist at the Royal Marsden Hospital and Emeritus Professor Biochemical Endocrinology
Institute of Cancer Research, London, United Kingdom
-
10:20 AM - 10:35 AM (CDT)Break with Virtual Exhibitors
-
10:35 AM - 11:30 AM (CDT)Heterogeneity of Breast Cancer Genomes
Funmi Olopade, MD
Associate Dean for Global Health, Director, Center for Clinical Cancer Genetics
University of Chicago, Chicago, Illinois
-
11:30 AM - 11:45 AM (CDT)Break with Virtual Exhibitors
-
11:45 AM - 12:40 PM (CDT)Where We Stand in Triple Negative Breast Cancer
Joyce O'Shaughnessy, MD
Medical Director, Breast Cancer Research Program
Baylor University, Dallas, Texas
-
12:40 PM (CDT)Adjournment
-